C ongress enacted the Health Insurance Portability and Accountability Act of 1996 (HIPAA) in an effort to make health insurance more affordable and accessible. Included in the Act were administrative simplification provisions requiring the U.S. Department of Health and Human Services (HHS) to adopt certain national standards. Specifically, HHS was to adopt standards dealing with certain electronic health care transactions, codes, identifiers, security, and privacy. The national standards were intended to make it easier for health care providers, including health plans, physicians, and hospitals, to process claims and other transactions electronically (HHS, 2002a) .
In its press release of June 3, 2002, HHS indicated [s] ecurity and privacy standards can promote higher quality care by assuring consumers that their personal health information will be protected from inappropriate uses and disclosures" (HHS, 2002a) .
It was believed also that national standards would save money by lowering the health care businesses' costs of developing and maintaining software, as well as by reducing the time and expenses needed to handle health care transactions (HHS, 2002a) .
GENERAL PROVISIONS
According to HIPAA, health plans, health care clearinghouses, and
ABOUT THE SECTION EOITOR
Ms. D'Arruda is an attorney from Raleigh, North Carolina with an interest in health care issues.
496
health care providers who conduct certain financial and administrative transactions electronically must comply with the final standards established by HHS. Others may voluntarily comply, but there is no requirement to do so. These covered entities are to be in compliance within 2 years following the adoption of the standards. However, Congress provided that small health plans would have 3 years to comply with the standards (HHS, 2002a) .
Generally, HHS works with industry standard setting groups to identify and develop standards,and then adopts the industry standards when appropriate. Proposed requirements are published and public comments are accepted.The HHS makes appropriate changes to ensure the HIPAA regulations can be implemented effectively and maintained over time to meet industry needs. Thereafter, the final standards are adopted (HHS, 2002a In addition, the final modifications provide some clarification about other provisions of the privacy rule.
Marketing
The final modification concerning marketing indicates a covered entity must obtain a person's prior written authorization to use protected health information for marketing purposes. Exceptions exist for face to face encounters and for communications involving a promotional gift of nominal value. The HHS clearly specified that covered entities are not allowed to sell lists of patients or enrollees to third parties or to disclose protected health information to third parties for the marketing activities of the third parties without first obtaining the affected persons' authorization. The privacy rule further provides that certain activities, such as providing information about discounts or informing patients of additional health plan coverage, are not considered marketing (HHS, 2002b) .
Consent and Notice
The HHS also issued final modifications to the consent and notice requirements to protect privacy, and, at the same time, eliminate any obstacles to treatment. The privacy rule currently requires covered entities "provide patients with notice of the patient's privacy rights and the privacy practices of the covered entity (HHS, 2002b) . This is a stronger notice requirement that forces direct treatment providers to make a "good faith effort" to acquire patients' written acknowledgement of the notice provided. In addition, the final privacy rule removes the mandatory consent requirements, thus making consent for routine health care delivery purposes (known as treatment , payment, and health care operation ) optional (HHS, 2002b) . The effect is to provide covered entities with the option of developing a consent process that works for that entit y, while not inhibiting access to health care. Any consent requirements already in place are allowed to continue under the final modifications (HHS, 2002b) .
Uses andDisclosures Related to FDA
The final privacy rule modification also permits covered entities to disclose protected health information, without authorization, to a person subject to the jurisdiction of the FDA for public health purposes related to the qua lity, safety or effectiveness of FDA-regulated products or activitie s such as co llecti ng or reporting adverse events, dangerous products, and defects or problems with FDAregulated products (HHS, 2002 b ).
The purpose is to assure necessary information is available to protect public health and safety (HHS, 2002b) .
Incidental Use andDisclosure
The HHS also issued final modifications related to incidental use and disclosure. The final modification recognizes some uses or disclosures of information may be incidental to an otherwise permitted use or disclosure. These uses or disclosures are not considered violations if the covered entity meets the reasonable safeguards and minimum necessary requirements. If the minimum necessary requirements and the reasonable safeguards are met, then the following are not considered in violation of the privacy rules, even if overheard or seen by passersby (HHS, 2002b): • Waiting room sign in sheets. • Keepin g patient charts at the hospital bedside. • Talking to patients in semiprivate rooms.
• Conferring at nurses' stations.
Authorization
Authorization requirements to the privacy rule were clarified in the final modifications. Pursuant to the final NOVEMBER 2002, VOL. 50, NO. 11 Legal Issues modifications, although patients must grant permission, in advance, for each type of nonroutine use or disclosure, providers do not have to use different forms for each type of nonroutine use or disclosure (HHS, 2002b) .
Minimum Necessary
In addition, the final modifications provide that uses and disclosures for which there is an authorization do not have to meet the minimum necessary standards. Previously, only certain types of auth or ization s were exempt. However, the minimum necessary requirement s are still effective for most other uses and disclosures, other than disclosure for treatment purposes. The HHS also provides in the preamble that the minimum necessary standard is not intended to obstruct disclosures necessary for workers' compensation programs-rather, the HHS indicated it would actively "monitor to ensure that workers' compensation programs are not unduly affected by the [privacy rule]" (HHS, 2002b) .
Business Associates
Covered entities, with the exception of small health plans, are allowed up to an additional year to change existing written contracts to come into compliance with the business associate requirement s (HHS, 2002b ). This extra time was intended to reduce the burden of renegotiating contracts all at once. In addition, the HHS provided sample business associate contract provisions (HHS, 2002b) .
Research
The research arena was also included in the final modifications. Specifically, the final modifications provide that researchers can use a single, combined form to obtain "informed consent for the research and authorization to use or disclose protected health information for such research" (HHS, 2002b) . In addition, the Privacy Board waiver of authorization process has been streamlined in the final modifications to more close ly follow the requirements governing federally funded research. The HHS also expanded the transition provisions to prevent the interruption of ongoing research (HHS, 2002b ) .
Limited Data Set
The final modifications also provide for the creation and dissemination of a limited data set (that does not include directly identifiable information) for research, public health, and health care operations (HHS, 2002b) .
The disclosure of this limited data set is conditioned on the covered entity and the recipient agreeing to limit the data set use to the specified purposes, to ensure the security of the inform ation, and "not to identify the informati on or use it to contact any individu al" (HHS, 2002b) .
OTHER PROVISIONS

Hybrid Entities
The final modifications allow "any entity that performs covered and noncovered functions to elect to use the hybrid entity provisions" (HHS, 2002b) . Such an entity has "additional discretion in designating its health care components" (HHS, 2002b) .
Changes in Legal Ownership
The HHS also clarified the definition of "health care operations" in the final mod ifications. Currently, a covered entity that "sells, or transfers assets to, or consolidates or merges with, an entit y [that] is, or will be, a covered ent ity upon completion of the transaction ," can use and disclose protected health information in connection with the transaction (HHS, 2002b) .
Disclosures of Enrollment and Disenrollment Information
Unde r the final modifications, group health plans, health insurance issuers, or HMO s acting for a group health plan can disclose to a plan sponso r. such as an employer, info rmat io n on whet her the individual is enro lled in or has disenrolled fro m a plan offe red by the spo nso r witho ut ame nding the plan docum ent s (HHS,2002b) .
Accounting of Disclosures
The final modifications "exe mpt disclosure s made pursuant to an authorization from the accounting requirements" because it is believed
